Add like
Add dislike
Add to saved papers

Tumor suppressive microRNA-708 targets Notch1 to suppress cell proliferation and invasion in gastric cancer.

Oncology Research 2018 Februrary 15
Growing evidence demonstrated that numerous microRNAs (miRNAs) may participate in the regulation of gastric carcinogenesis and progression. This phenomenon suggests that gastric cancer-related miRNAs can be identified as effective therapeutic targets for this disease. MiRNA-708 (miR-708) has recently been reported to be aberrantly expressed in several types of cancer and contribute to carcinogenesis and progression. However, the expression level, biological roles and underlying mechanisms of miR-708 in gastric cancer are poorly understood. Here, we found that miR-708 was down-regulated in gastric cancer tissues and cell lines. Down-regulated miR-708 expression was significantly associated with lymphatic metastasis, invasive depth and TNM stage. Further investigation indicated that ectopic expression of miR-708 prohibited cell proliferation and invasion in gastric cancer. Bioinformatics analysis showed that Notch1 was a potential target of miR-708. Notch1 was further confirmed as a direct target gene of miR-708 in gastric cancer by luciferase reporter assay, reverse transcriptionquantitative polymerase chain reaction and Western blot analysis. Furthermore, an inverse association was found between miR-708 and Notch1 mRNA level in gastric cancer tissues. In addition, restored Notch1 expression rescued the inhibitory effects on gastric cancer cell proliferation and invasion induced by miR-708 overexpression. Our findings highlight the tumor suppressive roles of miR-708 in gastric cancer and suggest that miR708 may be investigated as a novel target for gastric cancer treatment.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app